Literature DB >> 11334586

[Unnoticed hypothyroidism and myopathy due to lipid-lowering drugs].

G Gascón Ramón, F Bertomeu Blanch, V Meneu Montoliu, M D Fenollosa Tamarit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11334586      PMCID： PMC7675936          DOI： 10.1016/s0212-6567(01)78831-2

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  6 in total

1.  [Myopathy secondary to the treatment with inhibitors of HMG-CoA reductase].

Authors:  I Fuentes; C Aguilera
Journal:  Med Clin (Barc)       Date:  1998-11-28       Impact factor: 1.725

Review 2.  [Toxic myopathies related to the administration of hypolipidemic agents: are the drugs the only things responsible?].

Authors:  J Galiana; E Marchán; I Montés; S Pato
Journal:  Rev Clin Esp       Date:  1995-09       Impact factor: 1.556

3.  Lovastatin-induced myopathy in a hypothyroid patient.

Authors:  S Ahmad
Journal:  J Fam Pract       Date:  1995-09       Impact factor: 0.493

4.  Myxoedema revealed by simvastatin induced myopathy.

Authors:  M A al-Jubouri; P G Briston; D Sinclair; R H Chinn; R M Young
Journal:  BMJ       Date:  1994-02-26

5.  [Toxic myopathies: clinical, etiologic, and histologic study of 74 cases].

Authors:  J Fernández-Solá; E Pedrol; F Masanés; J Casademont; J M Grau; A Urbano-Márquez
Journal:  Med Clin (Barc)       Date:  1993-05-15       Impact factor: 1.725

6.  Electroneuromyography and neuromuscular findings in 16 primary hypothyroidism patients.

Authors:  M W Cruz; M Tendrich; M Vaisman; S A Novis
Journal:  Arq Neuropsiquiatr       Date:  1996-03       Impact factor: 1.420
  6 in total
  1 in total

1.  [Myopathy linked to statins in a patient with recently appeared hypothyroidism].

Authors:  C León Rodríguez; M Martínez González
Journal:  Aten Primaria       Date:  2005 Jul-Aug       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.